A Chronic Respiratory <i>Pasteurella multocida</i> Infection Is Well-Controlled by Long-Term Macrolide Therapy
-
- Seki Masafumi
- Division of Infection Control and Prevention, Osaka University Hospital, Japan
-
- Sakata Tomomi
- Laboratory for Clinical Investigation, Osaka University Hospital, Japan
-
- Toyokawa Masahiro
- Laboratory for Clinical Investigation, Osaka University Hospital, Japan
-
- Nishi Isao
- Laboratory for Clinical Investigation, Osaka University Hospital, Japan
-
- Tomono Kazunori
- Division of Infection Control and Prevention, Osaka University Hospital, Japan
この論文をさがす
抄録
A 57-year-old woman with severe bronchiectasis frequently received antibiotics, including penicillin, for acute exacerbations due to Pasteurella multocida. Although the bacteria showed a decrease in antibiotic susceptibility, her symptoms and X-ray findings became stable, and severe exacerbations were not observed for the last few years after a low-dose erythromycin treatment was started. The development of a respiratory infection with Pasteurella multocida is relatively uncommon, but it can be controlled by immunomodulation which is associated with long-term macrolide therapy.<br>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 55 (3), 307-310, 2016
一般社団法人 日本内科学会